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Characterization of the virulence
of a non-RT027, non-RT078 and binary
toxin-positive Clostridium difficile strain
associated with severe diarrhea
Chunhui Li1,2, Céline Harmanus3, Duolong Zhu2, Xiujuan Meng1, Shaohui Wang2, Juping Duan1, Sidi Liu1,
Chenchao Fu1, Pengcheng Zhou1, Ruisi Liu1, Anhua Wu1, Ed J. Kuijper3, Wiep Klaas Smits3, Lei Fu4 and Xingmin Sun2
Abstract
The expression of the Clostridium difficile binary toxin CDT is generally observed in the RT027 (ST1) and RT078 (ST11)
C. difficile isolates, which are associated with severe C. difficile infection (CDI). However, we recently reported that the
non-RT027 and non-RT078 C. difficile strain LC693 (TcdA+TcdB+ CDT+, ST201) caused severe diarrhea in a patient
in Xiangya Hospital in China. C.difficile LC693 is a member of Clade 3, and in this study, we identified LC693 as RT871
and compared its virulence and pathogenicity to those of C.difficile R20291 (TcdA+TcdB+CDT+, ST1/RT027), UK6
(TcdA+TcdB+CDT+, ST35/RT027), CD630 (TcdA+TcdB+CDT−, ST54, RT012), and 1379 (TcdA+TcdB+CDT−, ST54/RT012),
with strain 1379 being an epidemic C.difficile isolate from the same hospital. LC693 displayed a higher sporulation rate
than R20291, CD630 or strain 1379. LC693 was comparable to R20291 with respect to spore germination, motility, and
biofilm formation, but showed a faster germination rate, higher motility and a higher biofilm formation capability
compared to CD630 and strain 1379. The adherence of spores to human gut epithelial cells was similar for all strains.
The total toxin release of LC693 was lower than that of R20291, but higher than that of CD630 and strain 1379. Finally,
in a mouse model of CDI, LC693 was capable of causing moderate to severe disease. Our findings demonstrate the
pathogenicity of non-RT027 and non-RT078 binary toxin-positive C. difficile strains. Furthermore, our data indicate that
LC693 may be more virulent than strain 1379, an epidemic strain from the same hospital, and provide the first
phenotypic characterization of a non-RT027 and non-RT078 binary toxin-positive ST201 isolate.
Introduction
Clostridium difficile (C. difficile) is the leading etiologic
agent of antibiotic-associated diarrhea in developed
countries and is emerging as a worldwide healthcare
problem. Symptoms of C. difficile infection (CDI) range
from mild diarrhea to severe pseudomembranous
colitis, toxic megacolon, and death1–3. These symptoms
are primarily caused by two large protein toxins, namely,
TcdA and TcdB, which cause massive damage to the
intestinal mucosa and induce acute inflammatory
responses4–6. Approximately 20% of C. difficile strains
also produce a third toxin,named the ADP-
ribosyltransferase binary toxin (CDT)7–9. CDT increases
the adherence of C. difficile to epithelial cells10 and sup-
presses colonic eosinophilia11. Although the exact role of
CDT in the pathogenesis of CDI is not clear, hyperviru-
lent C. difficile strains expressing CDT have been reported
to cause a high mortality rate (approximately 60%)8,9.
In addition to toxins, factors such as spore formation,
the presence of flagella and biofilm formation likely play
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important roles in C. difficile transmission and coloniza-
tion12–15. CDI is transmitted via spores, which are meta-
bolically dormant and highly resistant to a variety of
disinfectants and antibiotics, allowing them to persist on
surfaces outside of the host12. The persistence of spores is
the root cause of the increased rates of recurrent CDI, and
it is estimated that up to 33 and 45% of patients will
develop relapse after the first and second episodes of CDI,
respectively16. Although the role of flagella in C. difficile
virulence may vary between strains, flagella play a role in
adherence and colonization17,18. Bacteria in biofilms are
known to be more resistant to different environmental
stresses, including antibiotics19. Interestingly, C. difficile
R20291, a PCR ribotype (RT)027 strain, produces higher
levels of toxins in vitro than CD63020 and has increased
sporulation and biofilm formation capabilities15.
C. difficile strains carrying the binary toxin (CDT) are
generally found among lineages that include the epidemic
RT027 (multilocussequence type (ST)1) and RT078
(ST11) strains, which are associated with severe clinical
symptoms in North America and Europe21. However,
both RT027 and RT078 strains are rarely reported in
China, with RT027 strains not having been reported in
China until 2013, and RT078 strains have not been
reported to date22. Instead, several toxigenic C. difficile
strains associated with severe symptoms have been
reported that belong to different clades23,24, indicating
that the epidemic genotypes of C.difficile in China are
different from those in North America and Europe. Pre-
viously, we reported a severe CDI case caused by the
binary toxin-positive, non-RT027, and non-RT078 C.
difficile strain LC693 belonging to ST20122,25. In this
study, several potential virulence factors of strain LC693
were evaluated in vitro and in vivo and were compared to
those of RT027 (ST1) and RT012 (ST54) strains.
Results
Strain LC693 is PCR ribotype 871 (RT871)
In our previous study, we showed that strain LC293
belongs to Clade 3, ST20122,26. Multiple clade 3 strains
have been described23, with the most common Clade 3 RT
in Europe being RT023 (3%)27,28. Similar to LC693,
RT023 strains are TcdA+, TcdB+, and CDT+ strains. We
performed capillary PCR ribotyping29 on LC693 against
the database of the Dutch National Reference Laboratory,
a center recognized by the European Centre for Disease
Prevention and Control (ECDC) for the typing of C. dif-
ficile. LC693 was determined to be an RT871 strain,
whereas the epidemic 1379 strain was readily confirmed
as an RT012 strain, consistent with its ST54 designation.
Strain LC693 efficiently sporulates
To evaluate the sporulation rate of C. difficile strains,
bacteria were cultured in 70:30 sporulation medium and
assessed for sporulation rates at 24 h post inoculation
(T24). For comparison, we evaluated the sporulation of the
reference strains R20291 (TcdA+TcdB+ CDT−; RT027/
ST1)30, CD630 (TcdA+TcdB+ CDT−; RT012/ST54), and
1379 (TcdA+TcdB+ CDT−; RT012/ST54), the latter of
which is an epidemic strain isolated from the same hos-
pital as LC693. R20291 was included as a well-
characterized control for a binary toxin-positive epi-
demic strain. An RT078 strain was not included, as phy-
logenetic analyses demonstrated that clade 3 strains are
more closely related to clade 2 (RT027/ST1) than clade 5
(RT078/ST11)31,32. Samples were visualized by micro-
scopy (data not shown), and the sporulation frequency
was defined as the number of spores divided by the
number of vegetative cells. As shown in Fig. 1, strain
LC693 exhibited a high sporulation rate (31.59 ± 4.82%),
significantly exceeding that of CD630 1.17 ± 0.24% (p=
0.0124). LC693 also showed a higher sporulation fre-
quency than R20291 and strain 1379, although these
differences were not significant (LC693, 31.59 ± 4.82%
versus R20291, 20.27 ± 4.34%, p= 0.1322; and versus
strain 1379, 18.61 ± 5.11%, p= 0.1205).
Similar results were obtained when the sporulation of
strains was examined by the frequency of ethanol-
resistant spore formation rather than by microscopic
enumeration. LC693 exhibited a high frequency of
ethanol-resistant sporulation 60.63 ± 11.49%, similar to
that observed for R20291 (54.55 ± 15.43%, p= 0.6986).
Strains CD630 and 1379 displayed a much lower level of
ethanol-resistant sporulation, 7.50 ± 3.54% and 22.34 ±
2.34%, respectively (LC693 vs CD630, p= 0.0247; LC693
vs 1379, p= 0.0454).
Fig. 1 Strain LC693 efficiently sporulates. C. difficile strains were
grown in 70:30 liquid sporulation medium and assayed for spore
formation after 24 h of incubation. a Sporulation frequencies were
plotted from direct enumeration of spores and vegetative cells in
micrographs (data not shown). b Sporulation frequency determined
by ethanol inactivation of vegetative cells. The means ± standard
deviation of the mean from three biological replicates are shown.
Student’s t-test was used to assess significance; ns not significant;
*p < 0.05
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Thus, LC693 sporulation is on par with the
RT027 strain and is significantly higher than that of the
RT012 strains under the conditions tested.
LC693 spores readily germinate
To compare early events in spore germination, we
incubated purified C. difficile spores in a buffer supple-
mented with glycine and taurocholic acid33. Germination
was monitored by plotting the ratio of the optical density
at 600 nm (OD600) at a given time to the OD600 at T0
(time zero). We observed a rapid decrease in optical
density indicative of germinating spores within the
first 4–6 min (Fig. 2a). This decrease was similar at 4 min
for LC693 (63.57 ± 3.01%) and R20291 (64.08 ± 7.64%,
p= 0.9195), but significantly greater than that observed
for CD630 and strain 1379 (69.55 ± 9.21% and 81.48 ±
1.79%, respectively, p= 0.0001, using one-way ANOVA).
Germination is accompanied by the release of calcium
dipicolinic acid (CaDPA) from spores18,19. A previous
study showed the complete release of CaDPA from
C. difficile spores in the presence of taurocholic acid
and glycine within ~30min34. We monitored CaDPA
release in real-time using an assay based on terbium
fluorescence35 (Fig. 2b). Consistent with previous studies,
we observed that R20291 exhibited a 100% CaDPA release
after approximately 30 min. The fluorescence signals from
the other strains did not saturate within this time frame
and were monitored for 60min, at which time LC693
reached an 89.48 ± 0.41% CaDPA release, which was sig-
nificantly higher than that observed for strains CD630 and
1379 (p < 0.001) (Fig. 2b).
Taken together, these results indicate that
LC693 spores more readily germinate than those of
strains 630 and 1379.
LC693 is motile with abundant peritrichous flagella
To assess the motility characteristics of C. difficile
vegetative cells, swimming assays were performed on 0.3%
nutrient agar plates. The radius of the bacterial growth
after incubation is correlated to swimming motility.
Strains LC693 (38.5 ± 0.71 mm) and R20291 (34 ± 1.41
mm) produced similar radii (Fig. 3) (p= 0.07), whereas
strains 1379 and CD630 appeared to be significantly less
motile, producing radii of 17.5 ± 0.71 and 18 ± 2.83 mm,
respectively LC693 vs CD630, p= 0.0036; LC693 vs 1379,
p= 0.0041).
We related the motility phenotype to the presence of
flagella through a transmission electron microscopy
(TEM) analysis. Consistent with our motility assay, we
observed that LC693 and R20291 cells presented abun-
dant peritrichous flagella, whereas CD630 and 1379 cells
did not appear to produce flagella (Fig. 4).The presence of
flagella therefore appears to correlate with the strong
swimming motility observed for strains LC693 and
R20291.
LC693 is highly capable of biofilm formation
The capability of the different C. difficile strains to form
biofilms was evaluated by crystal violet (CV) staining after
growth in microtiter plates36. Our results showed that
after incubating for 5 days, strain CD630 formed the least
amount biofilm on the abiotic surface, while all the other
assayed strains, including R0291 and LC693, exhibited
comparable levels of biofilm formation (Fig. 5). These
results indicate that LC693 is a competent biofilm-
forming strain.
LC693 spores adhere well to human gut epithelial cells
Purified C. difficile spores were used to evaluate
their adherence to HCT-8 human gut epithelial cells.
We observed no significant differences in spore
adherence among the strains (Fig. 6) (one way ANOVA:
p= 0.136). CD630 showed the highest adherence rate
(84.19% of adherent spores), whereas that observed
for LC693, R20291 and strain 1379 averaged approxi-
mately 60%.
Fig. 2 LC693 spores readily germinate. Purified C. difficile spores
were suspended in buffer supplemented with taurocholic acid and
glycine to induce germination. a Germination was monitored by
plotting the ratio of the OD600 at a given time to the OD600 at time
zero. **p= 0.0001, LC693 vs CD630 and strain 1379, one-way ANOVA.
b CaDPA release from germinating C. difficile spores was monitored
using Tb3+-fluorescence, and values were normalized to the
maximum signal obtained for strain R20291 at 30 min. (****p < 0.0001).
Data are reported as the means ± SD from three independent
experiments
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Fig. 3 LC693 is motile. A single colony was inoculated in the middle of a swim plate, which was incubated at 37 °C for the indicated time.
Swimming motility was quantitatively determined by measuring the radius of the zone of motility derived from a single colony. a–d Bacterial growth
resulting from strains LC693 (a), R20291 (b), CD630 (c) and 1379 (d) after 72 h of incubation (e). Radius of the bacterial growth derived from a single
colony of each strain. Data are reported as the means ± SD from three independent experiments, and differences were analyzed by Student’s t-test;
ns not significant; **p < 0.001
Fig. 4 LC693 forms peritrichous flagella. Flagella were visualized by transmission electron microscopy. Scale bar represents 1 μM. a LC693;
b R20291; c CD630; and d 1379
Li et al. Emerging Microbes & Infections           (2018) 7:211 Page 4 of 11
Strain LC693 is an effective toxin producer
The primary virulence factors of C. difficile are TcdA
and TcdB, which are encoded in a pathogenicity locus
together with the genes tcdR, tcdE, and tcdC37. C. difficile
clade 3 strains, including LC693, contain the mobile
genetic element Tn6218, which is inserted between the
tcdE and tcdA genes23. In this assay, we used both a
conventional ELISA and a commercial toxin detection kit
to assess extracellular TcdA/TcdB release to determine
whether this insertion leads to aberrant toxin expression
in strain LC693.
Strain UK6 (A+B+CDT+) is a hypervirulent BI/027/
NAP1 C. difficile strain that is routinely used for a mouse
model of CDI38,39. Since we used strain UK6 in the CDI
model as a reference strain, UK6 was also included in the
toxin assays. In the conventional ELISA assay, all the
assayed strains produced both TcdA and TcdB, with
the highest toxin concentrations of TcdA and TcdB
detected at 72 hours postinoculation (Fig. 7a, b). Gen-
erally, TcdA levels (Fig. 7a) were lower compared to
TcdB levels (Fig. 7b). Importantly, the dynamics of toxin
release into the medium were similar between LC693 and
the other strains overall, suggesting that the insertion of
Tn6218 does not markedly influence toxin regulation
or release (Fig. 7). At 72 h postinoculation, the TcdA
and TcdB levels did not significantly differ between the
RT027 strains (R20291 and UK6). For TcdA, we observed
that the RT027 strains produced approximately 2-fold
Fig. 5 LC693 can form a biofilm. Biofilm formation was measured by
crystal violet staining after 5 days of growth in reinforced clostridial
medium. Data are from three biological replicates and are reported as
the means ± SD. Student’s t-test was used for assess significance;
ns not significant; **p < 0.001
Fig. 6 LC693 spores adhere well to human gut epithelial cells.
HCT-8 cells were incubated with spores for 100 min under anaerobic
conditions, and the relative amount of adhered spores was
subsequently calculated. ns: not significant
Fig. 7 LC693 releases TcdA and TcdB. Toxin production at four
different time-points was measured. a TcdA concentration in culture
supernatant as determined by conventional ELISA; b TcdB
concentration in culture supernatant as determined by conventional
ELISA; c Total toxin released into the supernatant as measured
using the C. DIFFICILE TOX A/B II™ assay. Student’s t-test was used
for to assess significance; ns not significant; *p < 0.05; **p < 0.001;
***p= 0.0001
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more toxin than LC693 and the RT012 strains (CD630
and 1379) at 72 h postinoculation. For TcdB, toxin levels
were similar for the RT027 strains and strain 1379, but
lower for LC693 (p < 0.0001) and CD630 (p= 0.0109) at
72 h postinoculation.
Total toxin (i.e., the combined amount of measured
TcdA and TcdB released into the medium) determined
using the C. DIFFICILE TOX A/B II™ assay confirmed
that high levels of toxins were produced by the
RT027 strains (R20291 and UK6) under the conditions
tested (Fig. 7c). Although LC693 showed a lower toxin
production compared with R20291 and UK6 (p < 0.05), it
produced significantly higher amounts of total toxin
than strains CD630 and 1379 (p= 0.0181 and p= 0.0091,
respectively) (Fig. 7c). The observed difference using the
conventional ELISA may be related to the sensitivity
of the antibodies used in the assay.
Taken together, our data indicate that the temporal
regulation of toxin release by strain LC693 mirrors that of
other C. difficile strains that lack the Tn6218 insertion.
Furthermore, this strain produces toxins at a level that is
similar to or exceeds that of the RT012 strains tested.
Evaluation of LC693 virulence in a mouse model of CDI
Ultimately, the traits investigated above are likely to play
a role in disease development and pathogenesis. There-
fore, we evaluated the pathogenicity of LC693 in mouse
model of CDI. We did not include strain 1379 in the
animal experiments, since we sought to focus on com-
paring the virulence between LC693 and the hyperviru-
lent RT027 strains and the C. difficile strain CD630. In a
separate report, we will publish a more detailed study of
strain 1379, which was beyond the scope of the current
report. We observed that only a single animal succumbed
to a challenge with CD630, whereas mortality was higher
(40–70%) with the other assayed strains (Fig. 8). Although
the LC693-challenged group showed a trend toward
higher mortality (40%), this intermediate level was not
significantly different from the CD630- or RT027 (R20291
and UK6)-challenged groups. Notably, the RT027-
challenged group showed significant higher mortality
compared to the CD630-challenged group (p < 0.05).
When monitoring weight loss as an indicator of disease
severity, we observed that CD630-challenged mice
showed only moderate signs of disease, in line with the
low mortality observed for this group (Fig. 8b). In con-
trast, the groups challenged with the other strains showed
a sharp decrease in body weight at 1–3 days post chal-
lenge. Weight loss in the LC693-challenged group at 1, 2,
and 3 days post infection was significantly greater than
was observed for the CD630-challenged group. The
LC693-challenged group lost significantly more weight at
2, 3, 5, 6, and 7 days post infection and at 2 and 3 days
post infection compared to UK6- and R20291-challenged
groups, respectively (p < 0.05) (Fig. 8b). Overall, the
results from the mouse model of CDI suggest that LC693
is capable of causing moderate to severe disease.
Discussion
RT027/NAP1/ST1 C. difficile isolates have rapidly
emerged in the past decade as epidemic strains in North
America and Europe, resulting in CDI with high mor-
bidity and mortality in hospitalized patients. In addition,
the emerging RT078/ST11 C. difficile strains have been
reported to cause severe CDI at a similar rate40. Epidemic
RT027 strains have been associated with more severe
disease because of their increased production of TcdA
and TcdB (due to a tcdC deletion)40,41, high-level fluor-
oquinolone resistance and efficient sporulation42. How-
ever, in China, RT027 strains have not been reported until
2013, and RT078 strains have not been reported to date22.
Fig. 8 LC693 is virulent in a mouse model of CDI. Four groups of
mice (n= 10) were challenged with 106 spores of UK6, LC693, CD630,
or R20291. Mice were monitored for one week for survival (a) and
weight changes (b). Animal survival was analyzed by Kaplan–Meier
survival analysis with a log-rank test of significance (ns not significant,
p > 0.05). The mean relative weight of mice was analyzed for
significance using a Student’s t-test. *p < 0.05 between the CD630 and
LC693 groups at 1, 2 and 3 days post challenge; p < 0.05, between the
CD693 and UK6 groups at 2, 3, 5, 6, and 7 days post challenge; p < 0.05
between the LC693 and R20291 groups at 2 and 3 days post
challenge; and p > 0.05 between the UK6 and R20191 groups at all
assayed time points
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Instead, several severe symptoms associated with toxi-
genic C. difficile strains belonging to clades other than
RT027 and RT078 have been reported23,24, indicating that
the epidemic genotypes of C. difficile in China are dif-
ferent from those in North America and Europe.
LC693 belongs to clade 3 and ST201. A previous
phylogenetic analysis showed that clade 3 strains have a
closer evolutionary relationship with the RT027 strains
than with RT078 strains25, which is why we included
RT027 strains in our comparative characterization of
LC693.We showed that LC693 is an RT871 C. difficile
strain that sporulates well, germinates rapidly, readily
forms biofilms, and forms spores that are capable of
adhering to human gut epithelial cells. Importantly,
LC693 caused severe symptoms in both mice, as shown in
this work, and humans (from which it was previously
isolated).
To be able to produce toxins and cause disease symp-
toms, C. difficile spores need to germinate into vegetative
cells, making germination an important virulence feature.
Spore germination efficiency for severe CDI-implicated
C. difficile strains was shown to be significantly higher
than for strains associated with nonsevere CDI43.
In addition, C. difficile spores with a high germination
rate were observed to be more likely to cause recurrent
CDI44. We showed that strain LC693 efficiently sporulates
and germinates (Figs. 1 and 2), indicating its high
potential in promoting CDI.
Flagella are important colonization factors for a number
of enteropathogenic species, including C. difficile15. Fla-
gella may also play an important role in allowing bacteria
to adapt to their unique biological niches13,45. The results
of our study demonstrated that strain LC693 is highly
motile (Fig. 3), which was supported by the observation
that it had abundant peritrichous flagella (Fig. 4), similar
to the well-characterized epidemic RT027 isolate R20291.
Strikingly, these strains were also highly similar in their
capacity to form biofilms (Fig. 5), which may contribute
to their in vivo virulence45. We noted that our results
for strains CD630 and R20191 appear to be different
from those observed by others with respect to motility
and flagella production47. Baban and coworkers47 repor-
ted that CD630Δerm, an erythromycin sensitive strain
derived from CD630, was peritrichously flagellated and
that R20291 was monotrichously flagellated with only a
single flagellum. This group also showed the R20291
displayed decreased motility compared to 630Δerm in
swimming and swarming assays. Although we do not
know the reason for this discrepancy, differences in
experimental methods, minor differences in genetic
background47, and possible phase variation of flagellar
gene expression48,49 could contribute to the differences
in results. Our swimming motility results were consistent
with the TEM images. In addition, work from our
laboratory and others has shown that even seemingly
identical strains may not be genetically identical50.
Whereas we used strain CD630, the authors in the other
study used 630Δerm47, a strain derived from strain CD630
by serial passaging. Finally, even an isogenic strain can
behave differently due to reasons such as phase varia-
tion48,49. In agreement with our results, Stabler et al.30
showed that CD630 was less motile compared to R20291,
and Anjunwon-Foster and Tamayo48 showed that a “fla-
gellar switch” controlled the phase variable production of
flagella and toxins in R20291, which displayed peri-
trichous flagella with the flagellar switch on.
TcdA and TcdB are the major cause of CDI symp-
toms6,51, and the greater severity of RT027-associated
CDI has been partially attributed to the production of
higher amounts of toxins, which may or may not be
caused by mutations in tcdC50,52. The results of our pre-
vious study demonstrated that the toxin-encoding genes
of strain LC693 were highly homologous to those of
epidemic RT027/ST1 strains25. Although the release of
toxin by LC693 did not reach the levels observed for the
RT027 strains included in this work (UK6 and R20291),
the mortality for the LC693-challenged group (40%) was
not significantly different from that of the RT027 strains.
Furthermore, low toxin-producing C. difficile strains with
higher colonization capability are able to cause severe
infection outcomes (meeting presentation by Dr. Gayatri
Vedantam). In agreement with the observed virulence of
LC693 in the mouse model of CDI, our previous case
report also showed that this strain caused severe diarrhea
in an ICU-hospitalized patient22.
In summary, our data highlight the potential risk that
ST201 strains can cause epidemics with severe outcomes
in China.
Materials and methods
Measurement of sporulation rate
The microscopic evaluation of sporulation was per-
formed as previously described33. C. difficile strains were
cultured to mid-log phase in BHIS medium supplemented
with 0.1% taurocholate (Sigma) and 0.5% fructose at 37 °C
in an anaerobic chamber. A mixture of 70:30 sporulation
medium (70% SMC medium and 30% BHIS medium
containing 63 g Bacto peptone, 3.5 g protease peptone,
11.1 g BHI medium, 1.5 g yeast extract, 1.06 g Tris base,
0.7 g NH4SO4, and 15 g agar per liter) was prepared.
Cultures were subsequently diluted to an optical density
of 0.05 at OD600in 70:30 medium. Approximately 24 h
after the start of stationary phase (T24), 1–2ml samples
were withdrawn from the cultures. The samples were
pelleted at a maximum of 21,130 × g for 30 s and were
subsequently resuspended in 10 µl of double-distilled
water. A 2 µl aliquot of each concentrated culture was
placed on a thin layer slide, and the C. difficile cells were
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Gramstained and imaged with a Nikon Eclipse Ci-L
microscope at 100× magnification. A minimum of 500
cells from each strain were examined to calculate the
percentage of spores.
To assess ethanol-resistant spore formation, 500 µl of
samples from the sporulation medium were removed
from the anaerobic chamber and mixed 1:1 with 95%
ethanol for 15min to kill vegetative cells. The samples
were then returned to the anaerobic chamber, 100 µl of
the ethanol-treated cultures were mixed with 100 µl of
10% taurocholate, and the mixtures were plated onto
BHIS agar to induce C. difficile spore germination.The
ethanol-resistant CFU/ml was determined after incuba-
tion for 24 h and was divided by the total CFU/ml of the
nonethanol treated cultures. A minimum of three biolo-
gical replicates were performed for each strain.
Germination efficiency of C. difficile spores
Spore preparation
C. difficile strains were cultured in Clospore medium
under anaerobic conditions for 4 weeks53. For each strain,
a 50-ml culture was centrifuged, and the pellet was
washed five times to remove the medium, and resus-
pended in 3ml of sterile water. The suspension was
layered onto the top of 10 ml of 50% (wt/vol) sucrose in
water in a 15-ml tube. The gradient was centrifuged at
3200 × g for 20 min, after which the spore pellet at the
bottom was washed five times to remove the sucrose and
was resuspended in water. All spore preparations were
>99% pure, free of vegetative cells and debris54.
Determination of the initiation of spore germination
The initiation of spore germination was monitored
aerobically at OD600 (the initiation of C. difficile spore
germination is unaffected by the presence of oxygen)33. C.
difficile spore germination was initiated by suspending
spores in the germination solution (10 mM Tris, 150mM
NaCl, 100mM glycine, and 10mM taurocholic acid; pH
7.5). Spores were heat-shocked at 65 °C for 30min and
then placed on ice. Next, 5 µl of spores was diluted into
995 µl of buffer with or without germinant and mixed, and
the change in optical density at 600 nm (OD600) was
monitored. The ratio of the OD600 at time X (Tx) to the
OD600 at time zero (T0) was plotted against time.
The germination rates were determined using the slopes
of the linear portions of the germination plots, and the
data are reported as the averages from three independent
experiments with standard deviations.
Determination of Ca-DPA release
Ca-DPA (Calcium dipicolinic acid) release was mon-
itored in real time using a terbium fluorescence assay55,34.
An opaque 96-well plate was seeded with 125 µl/well of
the germination solution supplemented with 800 µM of
TbCl3. Heat (65 °C)-activated spores were sedimented for
1 min at 14,000 × g, and resuspended in an equal volume
of water. A 5 µl sample of a spore suspension (with an
OD600 of 30) was added to each well, and the Ca-DPA
release was monitored using a Molecular Devices Cyta-
tion™ 5 Imaging Multi-Mode Reader (BioTek, USA)
(excitation, 270 nm; emission, 545 nm; cutoff, 420 nm)55.
Motility assay
Motility assays were performed to assess the swimming
behavior of the C. difficile strains18,56. Motility plates were
prepared by adding 25ml of agar medium (37 g/L BHI
broth medium, 0.3% (w/v) DifcoBactoagar) into each
plate, and the agar was allowed to set overnight. The
softagar plates were then air-dried for 10min in a laminar
fume hood with airflow, transferred into the anaerobic
cabinet and allowed to reduce for 4 h prior to inoculation
with C. difficile strains. For each strain, a single colony
was inoculated in the middle of a swim plate, which was
then incubated at 37 °C for 72 h. Motility was quantita-
tively determined by measuring the radius of the zone of
motility at four different time-points (12, 24, 48, and 72 h).
Motility assays were performed in three replicates for
each strain, and each assay was repeated independently
three times.
TEM of flagella
Electron microscopy was performed to examine the
presence of flagella on the cell surface of the C. difficile
strains. C. difficile cells from mid-exponential cultures
were diluted in sterile water and then adsorbed onto
carbon formvar copper grids (Agar Scientific Ltd., UK) for
5 min. After air-drying overnight, the grid was quickly
washed once with sterile distilled water for 10 s. The air-
dried grid was visualized using a JOEL JEM1010 trans-
mission electron microscope operating at 80 kV.
Biofilm formation of C. difficile strains
C. difficile strains were cultured overnight in reinforced
clostridial medium (RCM, CM0149, OXOID) broth at 37 °
C for 24 h in an anaerobic chamber. Next, the culture was
diluted 1:100 in RCM broth and vortexed to mix well36.
The diluted cultures (200 µl) were dispensed into each
well of a 96-well microplate and incubated at 37 °C for
5 days in an anaerobic cabinet to allow for biofilm for-
mation. Subsequently, the plates were removed from the
anaerobic cabinet, and the planktonic cells and culture
supernatant were carefully removed using a Pasteur pip-
ette. An aliquot (200 μl) of 2.5% glutaraldehyde solution
was added into each of the drained wells, and the cells
were fixed for 30min. Next, the glutaraldehyde solution
was removed, and the fixed biomass was washed with
200 μl of PBS to remove the sedimented planktonic cells.
The PBS was discarded, and the wells were stained with
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200 μl of a 0.25% (w/v) aqueous CV solution for 10min.
The wells were washed with PBS five times and then were
allowed to air dry. The quantity of biofilm formed was
determined by adding 200 μl of solvent (1:1 ethanol and
acetone solution) to each well to dissolve the dye from
adherent cells (biofilm). The absorbance was measured
within 5 min of adding the solvent at 570 nm using a
Dynex plate reader. The microplate biofilm assay was
performed three times for all tested C. difficile strains.
Adhesion assay of C. difficile spores
The adherence of the C. difficile spores to human gut
epithelial cells was assessed as described previously57.
HCT-8 human gut epithelial cells were obtained from the
American Type Culture Collection (ATCC) and were
cultured in RPMI 1640 (Gibco) supplemented with 10%
(v/v) FBS, 10 mM L-glutamine, and 100 μg/mL penicillin/
streptomycin. After incubating for 5 days, the HCT-8 cells
(5 × 105 cells per ml in a 6 wells plate) were inoculated
with 100 µl of 5 × 107 spores/ml in sterile water, and the
plate was incubated for 100min at 37 °C in an anaerobic
chamber. After incubation, the cell-spore mixture was
washed three times with 1 × PBS via centrifugation at
800 × g for 1 min to remove any unattached spores. The
supernatants after centrifugation from each wash step
were collected to enumerate any spores that did not
adhere to the cells. The spores in the supernatant were
enumerated on prereduced BHI agar supplemented with
10% taurocholic acid (w/v). The controls included PBS
incubated with spores and RPMI incubated with spores,
and the adhesion assays were performed in triplicate. The
percentage of spore adherence was calculated using the
following formula: (initial CFU/ml – eluted CFU/ml)/
initial CFU/ml.
Determination of TcdA/TcdB production
Free toxin levels were determined at four different time
points (12, 24, 48, and 72 h postinoculation). Single
colonies of the strains were cultured in BHIS medium for
18–24 h (to stationary phase), and then were subcultured
into fresh TY medium (3% (w/v) tryptose, 2% (w/v) yeast
extract, 0.1% (w/v) thioglycollate, pH 7.4), adjusted to the
same OD600 value (0.05)
58. After incubation, the post-
culture broth of each time point was placed in a 50-ml
centrifuge tube, and centrifuged at 12,000 rpm for 10 min
at 4 °C. The supernatants were filtered through a mem-
brane filter with a 0.45-μm pore size, and the toxin con-
centrations in the supernatants were measured by ELISA.
Briefly, 96-well Costar microplates were coated with
100 µl of an anti-TcdA antibody (1 µg/ml) or an anti-
TcdB antibody (1 µg/ml) overnight in phosphate-buffered
saline (PBS) at 4 °C. The following day, each well was
blocked with 300 µl of blocking buffer (PBS+ 5% dry
milk) at RT for 2 h. Next, standards and samples were
added to each well (100 µl) in duplicate, and the samples
were incubated for 90min at 25 °C. After another set of
washes, HRP-chicken anti-C.difficile TcdA/TcdB (1:5000
dilution in PBS, Gallus Immunotech, Shirley, MA) was
added to wells for 30min at RT. After three washes, a TMB
Microwell peroxidase substrate for 20min at RT in the
dark. The reaction was stopped with 2 N of H2SO4, and the
absorbance was measured at 450 nm using a plate reader.
The total toxin concentration at four different
time points was also assessed using a C. DIFFICILE TOX
A/B II™ assay (TechLab, Inc., Blacksburg, VA) according
to the manufacturer’s instructions. Positive results for the
C. difficile TOX A/B II assay are indicated by OD450/620
values of ≥0.080, and negative results are indicated by
OD450/620 values of <0.080.
Evaluation of the virulence of C. difficile strains in mice
Six-week-old C57BL/6 female mice were purchased
from Charles River Laboratories, MA. All animal experi-
ments were approved by the Institutional Committee for
Animal Care and Use at the University of South Florida.
Forty mice were divided into four groups (n= 10) to be
challenged with spores of strains CD630, R20291, UK6,
and LC693. Mice were provided drinking water contain-
ing a mixture of six antibiotics, including kanamycin
(40 mg/kg), gentamycin (3.5 mg/kg), colistin (4.2 mg/kg),
metronidazole (21.5 mg/kg), and vancomycin (4.5 mg/kg)
for 5 days. Subsequently, mice were provided autoclaved
water for 2 days, followed by a single dose of clindamycin
(10 mg/kg) via intraperitoneal injection before being
challenged with 106C. difficile spores/mouse via oral
gavage as described previously59. After infection, the mice
were monitored daily for a week for survival, weight
changes, diarrhea, and other symptoms of disease. Diar-
rhea was defined as wet tails with loose or watery feces.
The number of recorded dead mice included the mice
that died after infection and those that were euthanized if
weight loss was greater than 20%.
Statistical analysis
Animal survival was analyzed by Kaplan–Meier survival
analysis with a log-rank test of significance. When com-
paring results for two groups, Student’s unpaired t-test
was used to assess significance. When comparing more
than two groups, one-way analysis of variance (ANOVA)
with post hoc analysis by Bonferroni tests was used.
The results are expressed as the means ± standard
errors of the means. Differences were considered
significant if p < 0.05 (*). All statistical analyses were
performed using GraphPad Prism.
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